Navigation Links
Mast Therapeutics Announces Positive Data In Model Of Heart Failure
Date:1/6/2014

>Details of the Study and Results
The objective of the study was to determine the effect of acute intravenous administration of MST-188 on left ventricular systolic and diastolic cardiac function in a model of chronic heart failure produced by multiple sequential intracoronary microembolizations.  A single dose of MST-188 (low or high dose) or placebo was administered over 2 hours.  Hemodynamic, ventriculographic, echocardiographic and electrocardiographic measurements were taken at baseline (prior to study drug administration) and at the following time-points after the start of study drug administration: 2 hours (end of administration), 24 hours, 1 week and 2 weeks.  Peripheral venous blood samples were obtained at the same time-points.  The improvements described above were calculated as the difference between baseline and mean values of each study group at each time-point using a one-way analysis of variance, with p<0.05 considered significant.  The study was conducted under the supervision of Dr. Hani N. Sabbah at Henry Ford Health System, a Michigan non-profit corporation. 

About Mast Therapeutics
Mast Therapeutics, Inc. is a publicly traded biopharmaceutical company headquartered in San Diego, California.  The Company is leveraging the MAST (Molecular Adhesion and Sealant Technology) platform, derived from over two decades of clinical, nonclinical and manufacturing experience with purified and non-purified poloxamers, to develop MST-188, its lead product candidate, for serious or life-threatening diseases with significant unmet needs.  MST-188 is a cytoprotective, hemorheologic, anti-inflammatory and anti-thrombotic agent that has potential utility in diseases or conditions characterized by microcirculatory insufficiency (endothelial dysfunction and/or impaired blood flow).&#
'/>"/>

SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Denmark and ATLANTA , ... 2015 the US Food and Drug Administration (FDA) cleared the ... Disorder in adult patients who have failed to receive satisfactory ... is a non-invasive technique for stimulating neural tissue in the ... Depressive Disorder. The procedure has been proven safe and effective ...
(Date:8/28/2015)... , Aug. 28, 2015 , ... Dr. Ra from Biostar , Published in ,Stem ... increase of lifespan through multiple IV administration of Adipose-derived ... and life expectancy found , Commercialization within 5 ... determined the possibility that adult mesenchymal stem cells (MSCs) ...
(Date:8/28/2015)... 28 de agosto de 2015   Royal ... participación en el  Congreso de la ESC de ... recientes y novedosas, entre ellas HeartModel A.I.  , ... personas y la tecnología con los protocolos de ... los tratamientos y permitir atención en el hogar. ...
Breaking Medicine Technology:Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5
... The proliferation of brand drug "copay coupon" promotions, ... brands, will increase costs by $681 million in Missouri ... employee plans, according to new research from Visante and ...  The use of these promotions by state and ...
... 16, 2011   The proliferation of brand drug "copay ... more expensive brands, will increase costs by $308 million ... and state employee plans, according to new research from ... Association (PCMA).  The use of these promotions by ...
Cached Medicine Technology:Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $681 Million in Missouri 2Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $308 Million in Arkansas 2
(Date:8/29/2015)... , ... August 29, 2015 , ... ... company to freely market and sell Arterosil and Arterosil HP, and that all ... LLC (DHS) sued Vascular Health Sciences, LLC (VHS) in the United States District ...
(Date:8/28/2015)... ... August 28, 2015 , ... An online provider of CPAP ... the purchase of CPAP equipment more affordable by offering shipping at no cost to ... CPAP products and orders of any size. My Cpap Store is located in Las ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... An ... that local pizza maker Paul LaRocco has gone through to open a pizzeria in ... and permitting process tends to take several months, but the current process, having already ...
(Date:8/28/2015)... VA (PRWEB) , ... August ... ... Risk Management for Medical Devices:, Understanding the FDA’s Position and Best Practices ... MD, http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally renowned expert ...
(Date:8/28/2015)... ... 28, 2015 , ... On May 30th, 2015, Best Drug Rehabilitation, a results-based ... With A Mission” benefit concert in Mendon, IL. Held in the Show Barn at ... support music education programs in the underfunded local school districts of Mendon at neighboring ...
Breaking Medicine News(10 mins):Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2
... fatty acid synthesis in brain cancer cells may offer ... deadly glioblastomas that are driven by amplified signaling of ... first-of-its-kind study by researchers at UCLA,s Jonsson Comprehensive Cancer ... for the formation of new membranes. The fatty acids ...
... and Spanish scientists have found the first potential immunological ... infected by the pandemic H1N1 virus. The ... hospitalized patients, 15 outpatients and 15 control subjects in ... July and August 2009. Researchers from the Hospital Clinico ...
... ... about-face, the secretive Central Intelligence Agency has requested documents from an investigative journalist, even ... of Information Act. , ... Walterville (Vocus) December 15, 2009 -- In a bizarre about-face, the secretive Central ...
... health care still needed for those with the virus, expert ... people in Switzerland who were infected with HIV decreased by ... therapy in 1996, a new study shows. , HIV is ... the suicide rate among those infected with HIV remained much ...
... , , PHILADELPHIA and ... To Cancer (SU2C) have joined together to create the first-ever ... to broaden awareness and raise critical funds for innovative ... Stand Up 2 Cancer On Demand will feature ...
... ... comprehensive solution , ... San Mateo, Calif. (PRWEB) December 15, 2009 -- Epocrates, Inc., developer of ... new premium software suite for the platform – Epocrates® Essentials Deluxe . Now ...
Cached Medicine News:Health News:Targeting brain cancer cell metabolism may provide new treatment 2Health News:Targeting brain cancer cell metabolism may provide new treatment 3Health News:First immunological clue to why some H1N1 patients get very ill or die 2Health News:CIA Requests its Own Documents from Author 2Health News:CIA Requests its Own Documents from Author 3Health News:HIV Therapy Linked to Fewer Suicides 2Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 2Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 3Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 4Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 5Health News:Epocrates Expands iPhone Offerings with New Premium Content 2Health News:Epocrates Expands iPhone Offerings with New Premium Content 3
... in the field of point of diagnostics pathology, ... a back-up instrument in routine pathology laboratories. With ... for the cover, the CM1100 can be transported ... transformer, it can be run on a car ...
... the world's smallest cryostat! It is a small, ... handwheel or lever operation. The compact chamber ensures ... decontaminating agents. An insulated cover is used to ... to reduce frosting when the unit is not ...
The HM 550 series is a uniquely progressive concept for use with frozen specimens of all types. User applications define module selection and make even serial sectioning enjoyable....
... The HM 560 Cryo-Star - a ... been incorporated which offer the users ... optionally motorized cryostat with retraction that ... independent specimen and knife cooling. This ...
Medicine Products: